Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study

Jara, Alejandro; A Undurraga, Eduardo; R Zubizarreta, José; González, Cecilia; Pizarro, Alejandra; Acevedo, Johanna; Leo, Katherinne; Paredes, Fabio; Bralic, Tomás; Vergara, Verónica; Mosso, Marcelo; Leon, Francisco; Parot, Ignacio; Leighton, Paulina; Suárez, Pamela; Carlos Rios, Juan; García-Escorza, Heriberto; Araos, Rafael

doi:10.1016/s2214-109x(22)00112-7

Public

Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study

Published in The Lancet Global Health • Apr 23, 2022

Authors:

Alejandro Jara

Eduardo A Undurraga

José R Zubizarreta

Abstract

BACKGROUND: Several countries have authorised or begun using a booster vaccine dose against COVID-19. Policy makers urgently need evidence of the effectiveness of additional vaccine doses and its clinical spectrum for individuals with complete primary immunisation schedules, particularly in countrie...

Subject

Booster (rocketry)

Medicine

Heterologous

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!